1. Cancer-Secreted Exosomal MiR-620 Inhibits ESCC Aerobic Glycolysis via FOXM1/HER2 Pathway and Promotes Metastasis
   Yanbo Zhu et al, 2022, Frontiers in Oncology CrossRef
2. MicroRNAs Involved in Carcinogenesis, Prognosis, Therapeutic Resistance, and Applications in Human Triple-Negative Breast Cancer
   Lei Ding et al, 2019, Cells CrossRef
3. Serum exosomal miR‐3662 down‐regulates the expression of RBMS3 to promote malignant progression and gemcitabine resistance of breast cancer cells
   Xiang Li et al, 2024, Chemical Biology & Drug Design CrossRef
4. Molecular Mechanisms, Biomarkers and Emerging Therapies for Chemotherapy Resistant TNBC
   Paola Ferrari et al, 2022, International Journal of Molecular Sciences CrossRef
5. Triple-Negative Breast Cancer: the Current Aspects of Pathogenesis and Therapies
   Shinjit Mani et al, 2022, BioNanoScience CrossRef
6. Down-regulating GRP78 reverses pirarubicin resistance of triple negative breast cancer by miR-495-3p mimics and involves the p-AKT/mTOR pathway
   Mian Liu et al, 2022, Bioscience Reports CrossRef
7. MicroRNA Expression Profiles and Breast Cancer Chemotherapy
   Matthew G. Davey et al, 2021, International Journal of Molecular Sciences CrossRef
8. Homoharringtonine demonstrates a cytotoxic effect against triple-negative breast cancer cell lines and acts synergistically with paclitaxel
   Riley Plett et al, 2022, Scientific Reports CrossRef
9. Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer—How We Can Rise to the Challenge
   Milica Nedeljković et al, 2019, Cells CrossRef
10. Breast cancer: miRNAs monitoring chemoresistance and systemic therapy
    Shivam Singh et al, 2023, Frontiers in Oncology CrossRef